首页 > 市场调查报告书 > 製药

睡眠辅助产品市场规模、份额和成长分析（按产品类型、睡眠障碍、分销管道、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1899673

睡眠辅助产品市场规模、份额和成长分析（按产品类型、睡眠障碍、分销管道、最终用户和地区划分）－2026-2033年产业预测

Sleep Aids Market Size, Share, and Growth Analysis, By Product Type (Mattresses & Pillows, Medications), By Sleep Disorder (Insomnia, Sleep Apnea), By Distribution Channel, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 244 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，助眠产品市场规模将达到 831.9 亿美元，到 2025 年将达到 881.4 亿美元，到 2033 年将达到 1399.6 亿美元，在预测期（2026-2033 年）内，复合年增长率为 5.95%。

睡眠障碍对个人的生活品质有着显着的影响，会导致一系列併发症，包括白天疲劳、学业和职业发展受阻、心理健康问题以及心臟病和糖尿病等慢性疾病。失眠、睡眠呼吸中止症、不宁腿症候群和发作性睡病等常见睡眠障碍凸显了有效治疗方法的紧迫性。治疗方案多种多样，从匹托利生和Modafinil等传统药物到Gabapentin、Zolpidem等替代疗法以及各种膳食补充剂，不一而足。改变生活方式，例如规律运动和维持良好的环境条件，也有助于改善睡眠品质。然而，人们对助眠药物副作用的担忧以及患者中药物过期率高的问题可能会阻碍助眠药物市场的发展，因此，开发安全有效的解决方案至关重要。

助眠产品市场驱动因素

受现代生活方式影响，全球人们的睡眠模式正在发生显着变化，这极大地推动了助眠产品市场的扩张。此外，消费者收入的提高和医疗保健服务的改善也促进了这一增长，越来越多的人寻求有效解决睡眠问题的方案。人们对优质睡眠对整体健康重要性的认识不断增强，推动了助眠产品的需求，促使更多人接受和使用旨在改善睡眠品质的各种产品。因此，生活习惯的改变和医疗保健资源的改善共同推动了助眠产品市场的持续成长和创新。

睡眠辅助剂市场的限制

由于创新技术的日益复杂化，睡眠辅助产品市场面临许多挑战，睡眠障碍的治疗难度也随之增加。此外，睡眠药物使用缺乏标准化指南和文件，也阻碍了其有效应用。睡眠设备安装和配置不当等问题进一步加剧了这些挑战，导致市场成长缓慢。这些因素阻碍了睡眠相关疾病的有效管理和治疗，从而限制了市场的潜在发展，并凸显了该领域加强监管和技术整合的必要性。

助眠产品市场趋势

由于失眠、不宁腿和嗜睡症等睡眠障碍的盛行率不断上升，全球助眠产品市场需求显着成长。消费者越来越倾向于寻求创新助眠产品，例如旨在提升舒适度和促进安稳睡眠的专用枕头和床垫。人们对睡眠对整体健康重要性的认识不断提高，进一步推动了这一趋势，促使人们更加青睐天然和药物助眠方案。随着生活节奏加快和压力水平上升，助眠产品市场预计将大幅扩张，反映出人们对获得优质睡眠以改善健康的日益重视。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Merck & Co., Inc.（USA）
Sanofi（France）
Koninklijke Philips NV（Netherlands）
Pfizer Inc.（USA）
GlaxoSmithKline PLC（UK）
SleepMed Inc.（USA）
Cadwell Laboratories Inc.（USA）
Natus Medical Incorporated（USA）
Fisher & Paykel Healthcare（New Zealand）
ResMed Inc.（USA）
Teva Pharmaceutical Industries Ltd.（Israel）
AstraZeneca（UK）
Takeda Pharmaceutical Company Limited（Japan）
Vanda Pharmaceuticals Inc.（USA）
Mylan NV（USA）
Koninklijke Philips NV（Netherlands）

结论与建议

简介目录

Product Code: SQMIG35I2107

Sleep Aids Market size was valued at USD 83.19 Billion in 2024 and is poised to grow from USD 88.14 Billion in 2025 to USD 139.96 Billion by 2033, growing at a CAGR of 5.95% during the forecast period (2026-2033).

Sleep disorders significantly impact individuals' quality of life, contributing to daytime fatigue and a myriad of complications, including challenges in academic and professional settings, mental health issues, and chronic conditions like heart disease and diabetes. Common disorders such as insomnia, sleep apnea, restless legs syndrome, and narcolepsy highlight the pressing need for effective interventions. Treatment options range from traditional medications like pitolisant and modafinil to alternatives including gabapentin, zolpidem, and various supplements. Lifestyle modifications, such as regular exercise and optimal environmental conditions, can enhance sleep quality. However, concerns over side effects associated with sleep aids and the prevalence of medication expiration among patients are likely to hinder growth in the sleep aids market, underscoring the need for safe and effective solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sleep Aids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sleep Aids Market Segments Analysis

Global Sleep Aids Market is segmented by product type, sleep disorder, distribution channel, end-user and region. Based on product type, the market is segmented into mattresses & pillows, medications, sleep apnea devices, sleep laboratories and other products. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleepwalking and other sleep disorders. Based on distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, sleep clinics and others. Based on end-user, the market is segmented into adults, children and elderly. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sleep Aids Market

The evolving sleep patterns among people worldwide, influenced by contemporary lifestyles, significantly fuel the expansion of the sleep aids market. Additionally, rising consumer affluence and enhanced access to healthcare services contribute to this growth, as more individuals seek effective solutions for sleep-related issues. The heightened awareness of the importance of quality sleep for overall well-being propels the demand for sleep aids, leading to a broader acceptance and utilization of various products designed to improve sleep quality. As a result, this combination of changing habits and increased accessibility to health resources positions the sleep aids market for continuous growth and innovation.

Restraints in the Sleep Aids Market

The Sleep Aids market faces challenges due to the rising complexity of innovative technologies that complicate the treatment of sleep disorders. Additionally, the absence of standardized guidelines and documentation for the use of sleep medications hinders effective application. Issues related to improper settings and configurations of sleep devices further exacerbate these difficulties, contributing to a stagnation in market growth. These factors collectively impede the potential advancement of the market, as they create barriers to the effective management and treatment of sleep-related conditions, highlighting the need for improved regulations and better technological integration in this sector.

Market Trends of the Sleep Aids Market

The global sleep aids market is witnessing a notable surge in demand, driven by a rising prevalence of sleep disorders such as insomnia, restless leg syndrome, and narcolepsy. Consumers are increasingly turning to innovative sleep-improving products, including specialized pillows and mattresses designed to enhance comfort and promote restful sleep. This trend is further fueled by heightened awareness of the importance of sleep for overall health, leading to a growing inclination towards natural and pharmacological sleep solutions. As lifestyles become more fast-paced and stress levels rise, the market for sleep aids is projected to expand significantly, reflecting a heightened focus on achieving quality sleep for improved well-being.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies
Customer & Buying Criteria Analysis

Global Sleep Aids Market Size by Product Type & CAGR (2026-2033)

Market Overview
Mattresses & Pillows
Medications
- Prescription-Based
- Over-The-Counter (OTC)
Sleep Apnea Devices
- Positive Airway Pressure (PAP) Devices
- Adaptive Servo-Ventilation (ASV) Devices
- Oral Appliances
- Masks & Accessories
Sleep Laboratories
Other Products
- Sleep Tracking Devices
- White Noise Machines

Global Sleep Aids Market Size by Sleep Disorder & CAGR (2026-2033)

Market Overview
Insomnia
Sleep Apnea
Restless Legs Syndrome
Narcolepsy
Sleep Walking
Other Sleep Disorders

Global Sleep Aids Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Sleep Clinics
Others

Global Sleep Aids Market Size by End-User & CAGR (2026-2033)

Market Overview
Adults
Children
Elderly

Global Sleep Aids Market Size & CAGR (2026-2033)

North America (Product Type, Sleep Disorder, Distribution Channel, End-User)
- USA
- Canada
Europe (Product Type, Sleep Disorder, Distribution Channel, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Sleep Disorder, Distribution Channel, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Sleep Disorder, Distribution Channel, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Sleep Disorder, Distribution Channel, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SleepMed Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cadwell Laboratories Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natus Medical Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fisher & Paykel Healthcare (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ResMed Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vanda Pharmaceuticals Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments